Clinical trial
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder
NCT00383786 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- June 30, 2009
- Enrollment
- 47 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ptsd